Regulatory News
Wednesday, August 10, 2016
UPDATE 2-Lilly breast cancer drug stumbles, but trial continues
Aug 10 (Reuters) - U.S. drugmaker Eli Lilly and Co
on Wednesday said it would continue a late-stage trial of its
experimental breast cancer drug in combination with a widely
used treatment even...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment